The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMC 3253069)

Published in Sex Transm Infect on June 02, 2011

Authors

S C Woodhall1, M Jit, K Soldan, G Kinghorn, R Gilson, M Nathan, J D Ross, C J N Lacey, QOLIGEN study group

Author Affiliations

1: Hull York Medical School, University of York, York, UK. sarah.woodhall@hpa.org.uk

Articles citing this

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model. BMJ (2011) 3.90

Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway. J Infect Dis (2014) 1.52

Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis (2013) 1.33

Genital warts and cost of care in England. Sex Transm Infect (2011) 1.19

Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11

Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys. PLoS One (2014) 1.06

Quality of life valuations of HPV-associated cancer health states by the general population. Sex Transm Infect (2012) 0.91

Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK. BMC Public Health (2013) 0.89

Predictors of Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men. Sex Transm Dis (2016) 0.80

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model. Hum Vaccin Immunother (2016) 0.78

Human papillomavirus-related psychosocial impact of patients with genital warts in China: a hospital-based cross-sectional study. BMC Public Health (2014) 0.78

Impairment of quality of life in symptomatic reproductive tract infection and sexually transmitted infection. J Reprod Infertil (2014) 0.76

Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men. Clin Infect Dis (2016) 0.75

Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model. BMC Public Health (2017) 0.75

HPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients. BMC Public Health (2013) 0.75

Articles cited by this

EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70

Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67

Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ (1998) 8.27

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis (2010) 5.39

The time trade-off method: results from a general population study. Health Econ (1996) 4.17

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ (2010) 3.41

Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ (2008) 3.08

The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis (2003) 2.72

Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect (2009) 2.30

Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol (1999) 2.13

(Not) warts and all. BMJ (2008) 2.09

Determining the cost of genital warts: a study from Ireland. Sex Transm Infect (2008) 1.60

Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine (2009) 1.45

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer (2010) 1.41

Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin (2006) 1.40

Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect (2008) 1.31

Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect (2008) 1.28

Genital warts and cost of care in England. Sex Transm Infect (2011) 1.19

Physical and psychological effects of anogenital warts on female patients. Sex Transm Dis (1993) 1.18

[Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France]. Gynecol Obstet Fertil (2007) 1.14

The costs of treating external genital warts in England and Wales: a treatment pattern analysis. Int J STD AIDS (2004) 1.14

Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect (2009) 1.08

Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. Sex Transm Dis (2009) 0.95

Patients with genital warts have a decreased quality of life. Sex Transm Dis (2009) 0.92

Long-term quality of life effects of genital warts - a follow-study. Dan Med Bull (2010) 0.84

(Not) warts and all. Government fully considered HPV vaccine. BMJ (2008) 0.80

Government decision on national human papillomavirus vaccine programme is a sad day for sexual health. Sex Transm Infect (2008) 0.78

Articles by these authors

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78

Genitourinary medicine services in the United Kingdom are failing to meet current demand. Int J STD AIDS (2001) 2.47

Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers. Am J Public Health (1995) 2.38

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ (1999) 2.31

Airway smooth muscle, tidal stretches, and dynamically determined contractile states. Am J Respir Crit Care Med (1997) 2.26

Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines. Pharmacoeconomics (2014) 2.24

Anaphylaxis to thiopentone: an unusual outbreak in a single hospital. Anaesth Intensive Care (1989) 1.92

Concentrations of gibberellin in chilled hazel seeds. Nature (1968) 1.88

Views and experiences of men who have sex with men on the ban on blood donation: a cross sectional survey with qualitative interviews. BMJ (2011) 1.86

Resurgence of syphilis in England: time for more radical and nationally coordinated approaches. Sex Transm Infect (2001) 1.85

Comparison of risk factors for four sexually transmitted infections: results from a study of attenders at three genitourinary medicine clinics in England. Sex Transm Infect (2000) 1.64

A SHOT in the arm for safer blood transfusion. BMJ (1996) 1.58

An automatic high-precision acrylamide gel fractionator. Anal Biochem (1972) 1.49

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45

The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance. Vox Sang (2000) 1.45

Intra-operative correction of acidosis, coagulopathy and hypothermia in combat casualties with severe haemorrhagic shock. Anaesthesia (2013) 1.44

Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect (2007) 1.44

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer (2010) 1.41

Quantitative importance of non-skeletal-muscle sources of N tau-methylhistidine in urine. Biochem J (1980) 1.38

Phytochrome control of maize coleoptile section elongation: the role of cell wall extensibility. Plant Physiol (1981) 1.34

Friction in airway smooth muscle: mechanism, latch, and implications in asthma. J Appl Physiol (1985) (1996) 1.34

Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect (2008) 1.31

Studies in Wild Oat Seed Dormancy: I. THE ROLE OF ETHYLENE IN DORMANCY BREAKAGE AND GERMINATION OF WILD OAT SEEDS (AVENA FATUA L.). Plant Physiol (1981) 1.31

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. HIV Med (2007) 1.30

The incidence and nature of rugby injuries experienced at one school during the 1982 rugby season. S Afr Med J (1983) 1.29

Viability of human diploid cells as a function of in vitro age. J Cell Physiol (1969) 1.26

Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine (2007) 1.24

A prospective social and molecular investigation of gonococcal transmission. Lancet (2000) 1.24

Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations. HIV Med (2010) 1.23

Prevalence of human papillomavirus antibodies in young female subjects in England. Br J Cancer (2007) 1.22

A sexual health and HIV strategy for England. BMJ (2001) 1.21

Demographic and behavioural profile of adults infected with chlamydia: a case-control study. Sex Transm Infect (2001) 1.18

Reverse transcriptase. The use of cloned Moloney murine leukemia virus reverse transcriptase to synthesize DNA from RNA. Mol Biotechnol (1997) 1.18

Phytochrome Control of Maize Coleoptile Section Elongation : A RAPID LOSS OF PHOTOREVERSIBILITY. Plant Physiol (1981) 1.15

A training technique for the daily chairing of monkeys. J Exp Anal Behav (1966) 1.13

Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. National Prospective Monitoring System Steering Group. AIDS (1999) 1.12

Antibodies to Chlamydia species in patients attending a genitourinary clinic and the impact of antibodies to C. pneumoniae and C. psittaci on the sensitivity and the specificity of C. trachomatis serology tests. Sex Transm Dis (1993) 1.12

Behavioural and demographic characteristics of attenders at two genitourinary medicine clinics in England. Genitourin Med (1997) 1.11

Erythromycin in the management of troublesome BCG lesions. Br J Dis Chest (1984) 1.10

Stimulus-artifact elimination in a multi-electrode system. IEEE Trans Biomed Circuits Syst (2008) 1.10

Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK. HIV Med (2008) 1.09

The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes. J Viral Hepat (2009) 1.07

Equine exertional rhabdomyolysis: activity of the mitochondrial respiratory chain and the carnitine system in skeletal muscle [see comment]. Equine Vet J (1991) 1.06

Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma. Sex Transm Infect (1999) 1.06

Reduction in wound infection rates by wound surveillance with postdischarge follow-up and feedback. Br J Surg (2006) 1.05

Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease. Neurology (2011) 1.05

Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer. Health Technol Assess (2010) 1.05

Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002). Int J STD AIDS (2008) 1.04

British Co-operative Clinical Group national survey on diagnostic issues surrounding genital herpes. MSSVD Special Interest Group on Genital Herpes and the British Co-operative Clinical Group. Sex Transm Infect (1999) 1.04

The danger of an inadequate water intake during prolonged exercise. A novel concept re-visited. Eur J Appl Physiol Occup Physiol (1988) 1.04

Rapid isolation of muscle and heart mitochondria, the lability of oxidative phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds. Mol Cell Biochem (1997) 1.04

A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol (1998) 1.03

Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study. HIV Med (2011) 1.03

Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011. Euro Surveill (2014) 1.02

The interrelation of demographic and geospatial risk factors between four common sexually transmitted diseases. Sex Transm Infect (2005) 1.00

Sexual histories, partnerships and networks associated with the transmission of gonorrhoea. Int J STD AIDS (1998) 1.00

A re-evaluation of the risk of transfusion-transmitted HIV prevented by the exclusion of men who have sex with men from blood donation in England and Wales, 2005-2007. Vox Sang (2011) 0.99

An outbreak of hepatitis A among young men associated with having sex in public venues. Commun Dis Public Health (2001) 0.98

British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. HIV Med (2010) 0.97

Labial tuberculosis: a unique cause of lip swelling complicating HIV infection. HIV Med (2002) 0.96

Poncet's disease in a patient with AIDS. Rheumatology (Oxford) (2001) 0.96

Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activity. Cell Growth Differ (1990) 0.95

Dengue. Nat Rev Microbiol (2004) 0.94

Persistence of two genotypes of Neisseria gonorrhoeae during transmission. J Clin Microbiol (2003) 0.93

The HCV National Register: towards informing the natural history of hepatitis C infection in the UK. J Viral Hepat (2000) 0.93

Markers of past syphilis in HIV infection comparing Captia Syphilis G anti-treponemal IgG enzyme immunoassay with other treponemal antigen tests. Int J STD AIDS (1995) 0.92

Patterns of homosexually acquired gonococcal serovars in Edinburgh 1986-90. Genitourin Med (1991) 0.92

Primary carnitine deficiency. J Clin Chem Clin Biochem (1990) 0.92

Height change caused by creep in intervertebral discs: a sagittal plane model. J Spinal Disord (1999) 0.91

Characterizing patients with multiple sexually acquired infections: a multivariate analysis. Int J STD AIDS (1997) 0.91

More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia. Int J STD AIDS (2010) 0.91

Expression of human serum albumin in the milk of transgenic mice. Transgenic Res (1992) 0.91

Parathyroid cysts: diagnosis and management. Laryngoscope (2001) 0.91

Do oral contraceptives inhibit Trichomonas vaginalis? Sex Transm Dis (1980) 0.90

Bacterial contamination of blood components. Vox Sang (2000) 0.90

A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts. Sex Transm Infect (2009) 0.90

Overview and summary: twenty-five-year followup of high-risk children. Schizophr Bull (1995) 0.89

Recurrent pleural effusion, protein-losing enteropathy, malabsorption, and mosaic warts associated with generalized lymphatic hypoplasia. Thorax (1971) 0.89

Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study. Health Technol Assess (2013) 0.88

Polymorph count for predicting non-gonococcal urethral infection: a model using Chlamydia trachomatis diagnosed by ligase chain reaction. Sex Transm Infect (2004) 0.88

Thoracic actinomycosis presenting as spinal cord compression. J Miss State Med Assoc (1990) 0.88

Referral patterns between primary care and genitourinary medicine. Int J STD AIDS (1999) 0.87

Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy. Arch Dis Child (2003) 0.86

GRASP: a new national sentinel surveillance initiative for monitoring gonococcal antimicrobial resistance in England and Wales. Sex Transm Infect (2001) 0.86

Survey of human immunodeficiency virus infection among pregnant women in England and Wales: 1990-93. Commun Dis Rep CDR Rev (1994) 0.86

The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs. Pharmacoeconomics (1998) 0.86

Hepatitis C in men who have sex with men in London--a community survey. HIV Med (2013) 0.85

The relationship between tuberculin reactions and the later development of tuberculosis: an investigation among Edinburgh school children in 1960-70. Tubercle (1971) 0.85

BHIVA Guidelines: coinfection with HIV and chronic hepatitis B virus. HIV Med (2003) 0.85

The effect of malonyldialdehyde on viscosity of normal and sickle red blood cells. Biochem Med Metab Biol (1990) 0.85

Comparison of a ligase chain reaction-based assay and cell culture for detection of pharyngeal carriage of Chlamydia trachomatis. J Clin Microbiol (2000) 0.85

Clone size variation in the human diploid cell strain, WI-38. J Cell Physiol (1973) 0.85

Escherichia coli DNA polymerase III tau- and gamma-subunit conserved residues required for activity in vivo and in vitro. J Bacteriol (2000) 0.84

Twenty-five-year followup of the Israeli High-Risk Study: current and lifetime psychopathology. Schizophr Bull (1995) 0.84

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine (2011) 0.82

How much sexually transmitted disease is not seen by genitourinary physicians? Genitourin Med (1995) 0.82

Fluoxetine effects on cerebral glucose metabolism. Neuroreport (1994) 0.82

The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy. HIV Med (2008) 0.82

Locus of control and mental health in adolescence and adulthood. Schizophr Bull (1995) 0.82